- Toward a new stage of PD-1 blockade cancer immunotherapyNagahiro, MinatoInternational Journal of Clinical Oncology, 2020, 25(5): 787-789.被引 3
- Phase I/IIa study of PM8001, a bifunctional fusion protein targeting PD-L1 and TGF-?, in patients with advanced tumorsGuo, Ye; Liu, Baogang; Lv, Dongqing; Cheng, Ying; Zhou, Tong; Zhong, Yahua; Hu, Changlu; Chen, Gang; Wu, Xiaohua; Yin, Yongmei; Wu, Lihua; Chen, Zhendong; Luo, Hong; Zhou, Xiaohong; Qin, Yanru; Yang, Yuxing; Luo, Suxia; Ma, Yanjie; Li, Yalin; Hu, GuoqiangAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.被引 5
- Tumor Liberated Protein (TLP) from lung cancer and perspectives for immunotherapyGiulio TarroDrug Designing: Open Access , 2012, 01(S1).
期刊论文
Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment
4被引5阅读
